Menveo meningococcal vaccine approved for children - ONA
Links shared publicly online about this topic.
- 538total visits
Menveo meningococcal vaccine approved for children - ONA
View full resource at oncologynurseadvisor.com
Tags: Vaccination, Diphtheria, Children's Health, FDA, Vaccine, Novartis, disease
Most Recently Shared on February 1, 2011 at 4:17 pm By:
Menveo meningococcal vaccine approved for children http://goo.gl/fb/UUtBV
FDA evaluates Novartis' meningitis vaccine Menveo for babies - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA is considering whether to approve Novartis' meningococcal vaccine Menveo for infants as young as 2 months. Menveo is already used in people ages 2 to 55. ” View full resource at smartbrief.com
Most Recently Shared on June 19, 2011 at 8:34 pm By:
Clara Song Doctor, Pediatrician, and Physician
FDA evaluates Novartis' meningitis vaccine Menveo for babies http://t.co/EAbEcM7
MENVEO (Meningitis vaccine) drug information from MPR
empr.com — “MENVEO (Meningitis vaccine) drug information for Immunization from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on May 18, 2011 at 4:23 am By:
MPR News: MENVEO: Adults and Children: approved for children 2-10 years of age. http://bit.ly/k2pa5b
Meningococcal Vaccine Approved for Infants and Toddlers - Physician's First Watch
firstwatch.jwatch.org — “The FDA has approved use of the meningococcal vaccine Menactra in children as young as age 9 months. The vaccine had already been approved for use in children 2 years and older. In announcing its . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on May 3, 2011 at 1:08 pm By:
DrD Physician, Doctor, and Internist
FDA approved Menactra for Infants and Toddlers - Physician's First Watch http://t.co/XS1EIvq
Meningococcal Vaccine Now Approved for Use in Infants | Health News
healthnews.com — “Today the FDA approved the use of Menactra in children as young as nine months for the prevention of invasive meningococcal disease. While the vaccine has been previously available to people over the age of two, it is now approved for use in children as young as nine months.” View full resource at healthnews.com
Most Recently Shared on April 25, 2011 at 4:50 pm By:
Meningococcal Vaccine Now Approved for Use in Infants http://ht.ly/4Gv6g
FDA approves Sanofi Pasteur's meningococcal vaccine
news-medical.net — “Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra, to include a two-dose schedule for infants and children 9 months through 23 months of age.” View full resource at news-medical.net
Most Recently Shared on April 25, 2011 at 11:44 am By:
Meningitis News: FDA approves Sanofi Pasteur's meningococcal vaccine: Sanofi Pasteur, the vaccines division of t... http://bit.ly/eCrvvc
Menactra, Meningococcal Vaccine For Infants From 9 Months Approved By FDA
medicalnewstoday.com — “Menactra, a vaccine for the prevention of invasive meningococcal disease for children from 9 months of age has been approved by the FDA (Food and Drug Administration). The vaccine, which is alread” View full resource at medicalnewstoday.com
Most Recently Shared on April 23, 2011 at 3:05 pm By:
MNT Pediatrics News Pediatrics and Health News
Menactra, Meningococcal Vaccine For Infants From 9 Months Approved By FDA http://mnt.to/3TYg #pediatrics
FDA Approves The First Vaccine To Prevent Meningococcal Disease In Infants And Toddlers
medicalnewstoday.com — “The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis sero” View full resource at medicalnewstoday.com
Most Recently Shared on April 23, 2011 at 7:05 am By:
MNT Infect Diseases Health News
FDA Approves The First Vaccine To Prevent Meningococcal Disease In Infants And Toddlers http://mnt.to/3TYf #viruses #bacteria
Medical News: FDA: Infants May Get Meningococcal Vaccine - in Pediatrics, Preventive Care from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the first meningococcal vaccine for use in toddlers and infants as young as nine months of age.” View full resource at medpagetoday.com
Most Recently Shared on April 23, 2011 at 3:07 am By:
RT @hrana: News: U.S. #FDA: Infants may get meningococcal vaccine http://bit.ly/ezBytq - how bout polio????
Menveo meningococcal vaccine approved for children - MPR
empr.com — “Novartis announced that the FDA has approved Menveo (meningococcal [Groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in children 2--10 years of age.” View full resource at empr.com
Most Recently Shared on February 1, 2011 at 3:43 pm By:
MPR News: Menveo meningococcal vaccine approved for children: Novartis announced that the FDA has approved Menve... http://bit.ly/eJpIuF
Expanded Age Group Approved for Meningococcal Vaccine : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on January 31, 2011 at 11:15 pm By:
Bob Finn - Medical News Net Health News
Novartis meningococcal vaccine approval expanded to children 2-10 y.o., but not infants. @elizmech reports. http://bit.ly/e9LDzB
New recommendations for MCV4 use - Related Stories - AAP SmartBrief
smartbrief.com — “The AAP Committee on Infectious Diseases approved two new modifications for the use of quadrivalent meningococcal vaccines (MCV4, Menactra, and Menveo) recommended by the Advisory Committee on Immunization Practices of the CDC. These new recommendations will affect the 2011 immunization schedule. De” View full resource at smartbrief.com
Most Recently Shared on January 31, 2011 at 4:17 pm By:
Clara Song Doctor, Pediatrician, and Physician
New recommendations for MCV4 use http://sbne.ws/r/6CiV
FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age
novartis.com — “FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age” View full resource at novartis.com
Most Recently Shared on January 31, 2011 at 2:19 pm By:
eyeonfda Pharma and Health Lawyer
FDA approves Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age - http://ow.ly/3NfGW
Menveo Vaccine Trial Shows Promise For Infant Meningococcal Disease Protection
medicalnewstoday.com — “After good Phase III trial results, Novartis announced it will submit Menveo (Meningococcal Group A, C, W135 and Y conjugate vaccine) for infants aged at least two months for approval. Submission” View full resource at medicalnewstoday.com
Most Recently Shared on October 25, 2010 at 9:28 pm By:
Menveo Vaccine Trial Shows Promise For Infant Meningococcal Disease Protection After good Phase III trial results, Nova.. http://dld.bz/3nfD
Novartis to file meningitis vaccine for infants
health.yahoo.net — “Swiss drugmaker Novartis AG wants to file its meningitis vaccine Menveo for use in small infants in the United States and Europe after a late-stage study with children of this age group was successful.” View full resource at health.yahoo.net
Most Recently Shared on October 25, 2010 at 10:40 am By:
Novartis to file meningitis vaccine for infants http://bit.ly/9NSGFK
Health Canada approves Novartis' Menveo for prevention of meningococcal disease
news-medical.net — “Novartis Pharmaceutical Canada Inc. announced that Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide CRM197 Conjugate Vaccine), a quadrivalent meningococcal conjugate vaccine was approved by Health Canada for active immunization of adolescents (11 to 18 years of age) and adults (19 to 55 years of age) to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.” View full resource at news-medical.net
Most Recently Shared on June 8, 2010 at 6:19 pm By:
Meningitis News: Health Canada approves Novartis' Menveo for prevention of meningococcal disease: Novartis Pharmac... http://bit.ly/cktD6u
Advertisement
